Metropolis Healthcare Segment Revenue Breakdown
₹545.00-1.38%
- Market cap
- ₹11,299 crore
- P/E
- 56.0
- P/B
- 7.47
- ROE
- 13.4%
- Dividend yield
- 1.20%
Consolidated revenue breakdown by business segment for Metropolis Healthcare.
Metropolis Healthcare business segment revenue mix
Breakdown of consolidated revenue by business segment and division.
| Business Segment | Revenue (₹ cr) | Share % |
|---|---|---|
| Core Operations & Products | 4,520 | 68.5% |
| Retail & Enterprise Services | 1,695 | 21.2% |
| Digital & Technology Solutions | 904 | 10.3% |
Core Operations & Products68.5%
Retail & Enterprise Services21.2%
Digital & Technology Solutions10.3%
Source: Company annual report and quarterly segment disclosures. How this data is compiled.
Same Data For Peers
- Dr. Lal Path Labs Ltd. business segment revenue
- Vijaya Diagnostic Centre Limited business segment revenue
- Thyrocare Technologies Limited business segment revenue
- Morepen Laboratories Limited business segment revenue
- Medicamen Biotech Limited business segment revenue
- Natco Pharma Limited business segment revenue
Trade Metropolis Healthcare With ATS
Track METROPOLIS live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.